Added to YB: 2025-01-31
Pitch date: 2025-01-30
EPIX [bullish]
ESSA Pharma Inc.
-4.97%
current return
Author Info
Central Tendency shares brief write-ups on typically overlooked stocks (special situations, small/microcaps, international, etc.) and financial concepts. Sign up for the newsletter.
Company Info
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer.
Market Cap
$75.5M
Pitch Price
$0.21
Price Target
2.60 (+1192%)
Dividend
N/A
EV/EBITDA
1.15
P/E
-2.65
EV/Sales
N/A
Sector
Biotechnology
Category
special_situation
On a Potential Sale of ESSA Pharma ($EPIX)
EPIX: Biotech cash shell trading 15% below PF net cash. Tang Capital (9.7% stake) likely to bid, given clean balance sheet & activist history. Other key holders (BVF, Soleus, BML) support fair outcome. Risks: Canadian incorporation, PFIC status for US investors.
Read full article (4 min)